drugset / Trial / NCT01407848

Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

NCT01407848

Phase 2 Completed 20 enrolled University of Cologne
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with Transient Tachypnoea.

Timeline

Start
2012-01
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 1 mg/kg Other